Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The organoids market will register positive growth with the overall reaching US$ 51.9 million in 2022. The demand for organoids is projected to surge with a projected CAGR of 13% from 2023 to 2033. A valuation of US$ 205.2 million is expected for the organoids market in 2033.
Organoids are self-organizing and microscopic 3D structures, which are grown from stem cells in vitro. This multipurpose innovation has prompted the advancement of a few novel human cancer models. In a preposterous decade, organoids are being progressively utilized in a scope of uses, including pathogenesis, disease modeling, regenerative medicine, and drug screening, and the pattern is set to keep shortly.
The global organoids market is being driven by research advancements in the field. Furthermore, the increase in the inclination towards personalized medicines is expected to result in increased use of organoids in the coming years. Till November 2020, there were around 21 ongoing clinical trials identified with organoids globally. This number is expected to rise in the approaching years, which is attributable to recent advancements in the scientific field.
Leading biopharma companies are focusing on expanding their product scope across various distribution channels in various countries around the world. To improve their industrial research activities, some companies are concentrating on collaborating directly with academic institutions. Few players, on the other hand, are concentrating on changing and building a broad product portfolio by bringing new innovative products into the global market.
Attributes | Details |
---|---|
Organoids Market Value (2022) | US$ 51.9 million |
Organoids Market Value (2023) | US$ 60.4 million |
Organoids Market Expected Value (2033) | US$ 205.2 million |
Organoids Market Projected CAGR (2023 to 2033) | 13% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing focus on oncological research has propelled the demand for organoids around the world. The United States has shown the highest development in the organoids market in the world.
This can be attributed to an increase in the number of patients suffering from various diseases, increased investment in R&D, commercialization of organoid models, and stem cell research. According to FMI’s analysis, organoids sales market grew at a CAGR of 15.6% from 2018 to 2022.
Funding for life science research and investments in organoids products is rising. These researches are undertaken by various organizations such as the National Institute of Allergy & Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services (DHHS), and others.
The National Institute of Allergy & Infectious Diseases includes applied and basic research to evaluate and develop therapeutics and diagnostics, which are funded through a variety of contracts and research grants. Sources of R&D spending include governments, commercial organizations as well as private funding. This will likely create opportunities for market growth. The total amount of research grants awarded by the National Institutes of Health (NIH) in the United States exceeded US$ 251 million over five years (2015 to 2019).
Cost-effectiveness Property to Propel Market Growth
Traditional methods for drug discovery are less pertinent and insufficient in comparison to the speed of developments in life science. Organoids are, in this way, expected to create a significant revenue share thanks to the increasing drug discovery applications in the coming years. For enhanced humanized therapeutics and medications, organoids are capable of identifying the target and non-target responses and connections of the candidate drug.
Organoids additionally have applications in shortlisting the potential medication molecules and removing the rest by considering the 'in-vitro' conditions, which are very near to the natural environmental surroundings. As indicated by the International Federation of Pharmaceutical Manufacturers and Associations, around 22% of the complete expenditure consumed on drug discovery is needed for preclinical testing.
The application of organoids for drug discovery reduces the extremely long process and saves expenditures, adding to the need for organoids in the market. North America continues to be a prominent region in organoids research, with sales growing at a relatively higher rate.
The Capability of Organoids to Meticulously Emulate the Distinct Cells of Organs Encourage Market Growth
The focus is on attaining a greater degree of resemblance to the cell-specific structure of the specific organ in vivo environmental conditions. This is thought to be the primary driver of the market. Organoids are used for cell toxicity monitoring, cell-based assays, and organ-specific cell functions. Because of the morphological and locomotion constraints imposed by the 2D setting, cell cultures in this setting are limited in their ability to reflect traits found in vivo systems.
Organoids' ability to meticulously imitate the individual cells of the organs from which they were created results in accurate tissue models. This aspect has emerged as a key growth driver. Organoids' diverse range of applications contributes to the market's rising demand from end users. Organoids allow for a more accurate simulation of living organism conditions and the generation of more relevant cell models. The expansion of the organoids market is expected to be driven by improved and better organoids systems.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
MNC to Play a Crucial Role in the Industry Growth
Multinational healthcare organizations play a vital role in ensuring that people in developing countries have access to high-quality care and medicines. Jobs are created, public policy is shaped, training is provided, and infrastructure is built as a result of their focus on providing access to health care services and medicines.
In recent years, pharmaceutical firms have posted good financial performance. The growing number of pharmaceutical companies and research and development activities not only create jobs but also necessitate manpower to provide quality services such as sterilization and infection control, which are essential for good manufacturing practices.
In 2017, the biopharmaceutical industry in the United States employed approximately 307,585 people, making a major contribution to industrial, state, and local economies. Expansion of the biopharmaceutical companies will emerge as a chief growth driver.
Organoids Tools Market:
Differentiating Aspects | Organoids Tools Market |
---|---|
CAGR (2023 to 2033) | 13% |
Market Valuation in 2023 | US$ 60.4 million |
Projected Market Value in 2033 | US$ 205.2 million |
Growth Factors | The growing number of pharmaceutical companies and research and development activities to provide quality services such as sterilization and infection control. |
Opportunities | The increase in the inclination towards personalized medicines is expected to result in increased opportunities of organoids in the coming years. |
Key Trends | Expansion of the biopharmaceutical companies will emerge as a key trend. |
3D Cell Culture Market:
Differentiating Aspects | 3D Cell Culture Market |
---|---|
CAGR (2023 to 2033) | 12.6% |
Market Valuation in 2023 | US$ 1.5 billion |
Projected Market Value in 2033 | US$ 4.8 billion |
Growth Factors | The 3D cell culture market is experiencing steady growth as a result of several variables such as the implementation of 3D cell culture models as substitutes for in vivo evaluation, advancements in large-scale automated cell culture infrastructure, and the increasing demand for transplants of organs. |
Opportunities | This new 3D cell culture system has opened up opportunities for applications in developing drugs, medical treatment, nanomaterial assessment, and basic life science research. |
Key Trends | Several sectors have been searching for and implementing a new platform that can substitute animal models or flask cell-culture structures, and organs-on-a-chip (OoCs) is now emerging as an appealing option for cell-based research and drug evaluation. |
United States to Take Over the Market
North America is predicted to remain one of the most attractive markets during the forecast period, according to Future Market Insights. The United States' high healthcare spending is one of the main factors supporting the market growth. Healthcare spending grew at a faster rate of about 4.6% in 2019 than overall economic growth of 4.0 percent in the United States calculated by Gross Domestic Product (GDP), according to CMS' Office of the Actuary estimates.
The United States remains one of the world's largest markets for biopharmaceuticals, making it a lucrative market for organoids manufacturers. The United States dominated the organoids industry, owing to an increase in the execution of organoid-based examination models in the biotechnology sector in both the United States and Canada. These cutting-edge developments have helped scientists resolve the limitations of 2D cell culture phases, as 3D organoids provide a microenvironment that mimics the properties of human tissue structures.
This allows for the prediction of in vivo test results. High per capita healthcare spending and favorable healthcare policies have supported the introduction of organoids in the United States. The United States accounted for a market share of 46.1% in 2022.
Japan Market to Expand Owing to Collaboration Activities
The market registered swift expansion in Japan, which is attributable to consistent advancements in the area of stem cell research. An increase in collaborations among key market players is observed, which is aiding the overall expansion of the market. For example, in March 2020, Nichirei Biosciences and UPM Biomedicals collaborated together to give UPM culture products in Japan. This upgraded the accessibility of normal hydrogels for organoid culture.
During the assessment period, research and development activities are expected to play a significant role in the overall development of the Japanese organoids market. Furthermore, it is expected that increasing collaborations between researchers and medical experts would bolster the production of complex organoids.
Two recent findings are expected to improve Japan's overall prospects for next-generation organoid production. In August 2020, a group of scientists from Cincinnati Children's Hospital Medical Center and Japan announced a new research partnership. The findings from the recent research partnership, according to the researchers, would likely be one of the most important factors in the growth of a new generation of complex organoids. As a result, the market for organoids in Japan is expected to increase. Japan accounted for a market share of 4.7% in 2022.
The market in the United Kingdom is likely to grow at a rapid pace during the forecast period. Over the next few years, the organoids market in the country is expected to be driven by the production of cerebral organoids for neurological disorders, as well as an increase in the prevalence of infectious and other diseases.
During the forecast period, investments in cancer, liver diseases, gastrointestinal diseases for organ regeneration, and stem cell research are expected to fuel the organoids market in Europe. Over the forecasts period the united Kingdom is expected grow at CAGR of 12.9%.
Intestinal Organoids Segment to Dominate the Market
The intestinal organoids will continue accounting for a maximum of the global share among products through the forecast period. Intestinal organoids offer higher availability compared to other organoids, which are the leading factors behind the dominance of this segment.
Toxicology, drug discovery, and cancer research all depend heavily on organoid cultures. This is due to the fact that organoids have a tumor-like growth pattern, which can be cultured to produce a large number of cells of uniform shape and size, and can be studied, morphologically measured, and counted using a variety of instruments and techniques. Intestinal organoids accounted for a market share of 37.42% in 2022.
Demand of Studying Disease Epidemiology to Propel The Market Growth
Accounting for more than 1/3rd of the overall market share, bio-banking continues to account for the bulk use of organoids. The demand is due to a higher inclination toward studying disease epidemiology and human developmental biology. Moreover, the rise in the trend of preserving organ-specific tissue diversity and a quest to study diseases worldwide is attributed to the market growth of this segment among all applications. The bio-banking segment accounted for a market share of 34.96% in 2022.
Academic and Research Institutes segment to Generate Highest Market Share
The Academic and Research Institutes segment is estimated to hold the largest revenue share of 68.8% in 2022, owing to the higher adoption of organoids into research studies. Organoids' possible therapeutic applications have been increasing in academic and research institutes.
The rapid growth rate of the academic and research institutes segment is expected to be driven by the increased adoption of organoid culture in university projects and government-based research bodies.
In June 2019, for example, researchers from the Stanley Center and Harvard University for Psychiatric Research (Broad Institute) developed enhanced human brain organoids to help research neurological disorders. Thus, this in turn is expected to increase the demand for organoids.
Companies operating in the organoids market are aiming at strategic collaborations with other manufacturers to expand their product manufacturing and address the demand of an expanding patient pool.
Attribute | Details |
---|---|
Organoids Market Value (2023) | US$ 60.4 million |
Organoids Market Expected Value (2033) | US$ 205.2 million |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ million for Value |
Key Regions Covered |
|
Key Countries Covered |
|
Key Segments Covered |
|
Key Companies Profiled |
|
Customization & Pricing | Available upon Request |
The market is valued at US$ 60.4 million in 2023.
Cellesce Ltd., DefiniGEN, and Qgel are key market players.
The market will reach US$ 205.2 million by 2033.
Advancements in technology will drive the market prospects.
From 2018 to 2022, the market registered a CAGR of 15.6%.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Intestinal Organoids 5.3.2. Hepatic Organoids 5.3.3. Pancreatic Organoids 5.3.4. Colorectal Organoids 5.3.5. Neural Organoids 5.3.6. Others 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Bio-banking 6.3.2. Biomedical Research and Drug Discovery 6.3.3. Regenerative Medicine 6.3.4. Cancer Research 6.3.5. Therapeutic Tools 6.3.6. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Biopharmaceutical Companies 7.3.2. Contract Research Organizations 7.3.3. Academics and Research Institutes 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Singapore 12.2.1.5. Thailand 12.2.1.6. Indonesia 12.2.1.7. Australia 12.2.1.8. New Zealand 12.2.1.9. Rest of Asia Pacific 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Product Type 14.1.2.2. By Application 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Product Type 14.2.2.2. By Application 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Product Type 14.3.2.2. By Application 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Product Type 14.4.2.2. By Application 14.4.2.3. By End User 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Product Type 14.5.2.2. By Application 14.5.2.3. By End User 14.6. UK 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Product Type 14.6.2.2. By Application 14.6.2.3. By End User 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Product Type 14.7.2.2. By Application 14.7.2.3. By End User 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Product Type 14.8.2.2. By Application 14.8.2.3. By End User 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Product Type 14.9.2.2. By Application 14.9.2.3. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Product Type 14.10.2.2. By Application 14.10.2.3. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Product Type 14.11.2.2. By Application 14.11.2.3. By End User 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Product Type 14.12.2.2. By Application 14.12.2.3. By End User 14.13. Singapore 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Product Type 14.13.2.2. By Application 14.13.2.3. By End User 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Product Type 14.14.2.2. By Application 14.14.2.3. By End User 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Product Type 14.15.2.2. By Application 14.15.2.3. By End User 14.16. Australia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Product Type 14.16.2.2. By Application 14.16.2.3. By End User 14.17. New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Product Type 14.17.2.2. By Application 14.17.2.3. By End User 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Product Type 14.18.2.2. By Application 14.18.2.3. By End User 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2022 14.19.2.1. By Product Type 14.19.2.2. By Application 14.19.2.3. By End User 14.20. Israel 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2022 14.20.2.1. By Product Type 14.20.2.2. By Application 14.20.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Cellesce Ltd 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. DefiniGEN 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Qgel 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Hubrecht Organoid Technology (HUB) 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. OcellO B.V. 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. STEMCELL Technologies Inc. 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Thermo Fisher Scientific Inc. 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Organovo Holdings Inc. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Takara Bio Inc. 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Corning Incorporated 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. 3Dnamics Inc. 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Volume (Units) Forecast by Region, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 4: Global Market Volume (Units) Forecast by Product Type, 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 6: Global Market Volume (Units) Forecast by Application, 2018 to 2033 Table 7: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 8: Global Market Volume (Units) Forecast by End User, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: North America Market Volume (Units) Forecast by Country, 2018 to 2033 Table 11: North America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 12: North America Market Volume (Units) Forecast by Product Type, 2018 to 2033 Table 13: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 14: North America Market Volume (Units) Forecast by Application, 2018 to 2033 Table 15: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 16: North America Market Volume (Units) Forecast by End User, 2018 to 2033 Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Latin America Market Volume (Units) Forecast by Country, 2018 to 2033 Table 19: Latin America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 20: Latin America Market Volume (Units) Forecast by Product Type, 2018 to 2033 Table 21: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 22: Latin America Market Volume (Units) Forecast by Application, 2018 to 2033 Table 23: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 24: Latin America Market Volume (Units) Forecast by End User, 2018 to 2033 Table 25: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: Europe Market Volume (Units) Forecast by Country, 2018 to 2033 Table 27: Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 28: Europe Market Volume (Units) Forecast by Product Type, 2018 to 2033 Table 29: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 30: Europe Market Volume (Units) Forecast by Application, 2018 to 2033 Table 31: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 32: Europe Market Volume (Units) Forecast by End User, 2018 to 2033 Table 33: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 34: Asia Pacific Market Volume (Units) Forecast by Country, 2018 to 2033 Table 35: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 36: Asia Pacific Market Volume (Units) Forecast by Product Type, 2018 to 2033 Table 37: Asia Pacific Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 38: Asia Pacific Market Volume (Units) Forecast by Application, 2018 to 2033 Table 39: Asia Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 40: Asia Pacific Market Volume (Units) Forecast by End User, 2018 to 2033 Table 41: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 42: MEA Market Volume (Units) Forecast by Country, 2018 to 2033 Table 43: MEA Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 44: MEA Market Volume (Units) Forecast by Product Type, 2018 to 2033 Table 45: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 46: MEA Market Volume (Units) Forecast by Application, 2018 to 2033 Table 47: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 48: MEA Market Volume (Units) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Volume (Units) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 10: Global Market Volume (Units) Analysis by Product Type, 2018 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 13: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 14: Global Market Volume (Units) Analysis by Application, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 17: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 18: Global Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 21: Global Market Attractiveness by Product Type, 2023 to 2033 Figure 22: Global Market Attractiveness by Application, 2023 to 2033 Figure 23: Global Market Attractiveness by End User, 2023 to 2033 Figure 24: Global Market Attractiveness by Region, 2023 to 2033 Figure 25: North America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 26: North America Market Value (US$ Million) by Application, 2023 to 2033 Figure 27: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 28: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 29: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 30: North America Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 33: North America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 34: North America Market Volume (Units) Analysis by Product Type, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 38: North America Market Volume (Units) Analysis by Application, 2018 to 2033 Figure 39: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 40: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 41: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 42: North America Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 43: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 44: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 45: North America Market Attractiveness by Product Type, 2023 to 2033 Figure 46: North America Market Attractiveness by Application, 2023 to 2033 Figure 47: North America Market Attractiveness by End User, 2023 to 2033 Figure 48: North America Market Attractiveness by Country, 2023 to 2033 Figure 49: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 50: Latin America Market Value (US$ Million) by Application, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 52: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 54: Latin America Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 57: Latin America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 58: Latin America Market Volume (Units) Analysis by Product Type, 2018 to 2033 Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 61: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 62: Latin America Market Volume (Units) Analysis by Application, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 66: Latin America Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 67: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 69: Latin America Market Attractiveness by Product Type, 2023 to 2033 Figure 70: Latin America Market Attractiveness by Application, 2023 to 2033 Figure 71: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 73: Europe Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) by Application, 2023 to 2033 Figure 75: Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 76: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 77: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 78: Europe Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 79: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 80: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 81: Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 82: Europe Market Volume (Units) Analysis by Product Type, 2018 to 2033 Figure 83: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 84: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 85: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 86: Europe Market Volume (Units) Analysis by Application, 2018 to 2033 Figure 87: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 88: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 89: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 90: Europe Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 91: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 92: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 93: Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 94: Europe Market Attractiveness by Application, 2023 to 2033 Figure 95: Europe Market Attractiveness by End User, 2023 to 2033 Figure 96: Europe Market Attractiveness by Country, 2023 to 2033 Figure 97: Asia Pacific Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 98: Asia Pacific Market Value (US$ Million) by Application, 2023 to 2033 Figure 99: Asia Pacific Market Value (US$ Million) by End User, 2023 to 2033 Figure 100: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 101: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 102: Asia Pacific Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 103: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 104: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 105: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 106: Asia Pacific Market Volume (Units) Analysis by Product Type, 2018 to 2033 Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 110: Asia Pacific Market Volume (Units) Analysis by Application, 2018 to 2033 Figure 111: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 112: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 113: Asia Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 114: Asia Pacific Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 115: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: Asia Pacific Market Attractiveness by Product Type, 2023 to 2033 Figure 118: Asia Pacific Market Attractiveness by Application, 2023 to 2033 Figure 119: Asia Pacific Market Attractiveness by End User, 2023 to 2033 Figure 120: Asia Pacific Market Attractiveness by Country, 2023 to 2033 Figure 121: MEA Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 122: MEA Market Value (US$ Million) by Application, 2023 to 2033 Figure 123: MEA Market Value (US$ Million) by End User, 2023 to 2033 Figure 124: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: MEA Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 127: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 128: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 129: MEA Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 130: MEA Market Volume (Units) Analysis by Product Type, 2018 to 2033 Figure 131: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 132: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 133: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 134: MEA Market Volume (Units) Analysis by Application, 2018 to 2033 Figure 135: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 136: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 137: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 138: MEA Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 139: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 140: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 141: MEA Market Attractiveness by Product Type, 2023 to 2033 Figure 142: MEA Market Attractiveness by Application, 2023 to 2033 Figure 143: MEA Market Attractiveness by End User, 2023 to 2033 Figure 144: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports